Insomnia Disorder
Insomnia disorder is a common sleep condition characterized by difficulty falling asleep, staying asleep, or waking up too early, leading to daytime fatigue and difficulty concentrating.
Daridorexant for Insomnia in Alzheimer's Patients
We are studying whether daridorexant can improve sleep quality in individuals with mild cognitive impairment and mild to moderate Alzheimer's disease. This trial aims to evaluate its effects on sleep duration, daytime functioning, and overall health.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 60 and 85 years old?
- Do you often feel dissatisfied with your sleep quantity or quality, despite having enough time to sleep?
- Is your total sleep time less than 6 hours on at least 3 nights per week?
- Do you have a history of significant depression or other serious psychiatric conditions?
- Are you currently taking any medications that affect sleep, like antidepressants or sleep aids?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
University Hospital Of Montpellier
NEUROLOGY
Montpellier, France
Sponsor: University Hospital Of Montpellier
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.